Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections

Clinical Infectious Diseases

Volumn 53, Issue 9, 2011, Pages

  Gottfredsson, Magnus ^a,c,e   Reynisson, Ingi K ^a   Ingvarsson, Ragnar F ^a   Kristjansdottir, Hafrun ^b,c   Nardini, Martina V ^c   Sigurdsson, Jon F ^b,c   Schneerson, Rachel ^d   Robbins, John B ^d   Miller, Mark A ^e  

^a Department of Medicine ^*  (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BECK DEPRESSION INVENTORY; BLEEDING; COGNITIVE DEFECT; CONTROLLED STUDY; DATA BASE; DEPRESSION ANXIETY STRESS SCALE; DISEASE PREDISPOSITION; EPIDEMIC MENINGITIS; FEMALE; FOLLOW UP; HEARING LOSS; HUMAN; ICELAND; INFECTION COMPLICATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MENTAL HEALTH; MIGRAINE; NEISSERIA MENINGITIDIS; PATIENT HEALTH QUESTIONNAIRE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SKIN NECROSIS; STRUCTURED INTERVIEW; SURVIVOR;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ARTHRITIS; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ICELAND; IMMUNOGLOBULIN G; MALE; MENINGITIS, MENINGOCOCCAL; MIDDLE AGED; MIGRAINE DISORDERS; NERVOUS SYSTEM DISEASES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80054086305     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir500     Document Type: Article

References (34)

1. van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13:144-66. (Pubitemid 30039347)
2. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009; 27(Suppl 2):B51-63.
3. Gottfredsson M, Diggle MA, Lawrie DI, et al. Neisseria meningitidis sequence type and risk for death, Iceland. Emerg Infect Dis 2006; 12: 1066-73. (Pubitemid 44061274)
4. Heckenberg SG, de Gans J, Brouwer MC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 2008; 87:185-92.
5. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:317-28.
6. Buysse CM, Vermunt LC, Raat H, et al. Surviving meningococcal septic shock in childhood: long-term overall outcome and the effect on health-related quality of life. Crit Care 2010; 14:R124.
7. Tan LK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N Engl JMed 2010; 362:1511-20.
8. Finne J, Finne U, Deagostini-Bazin H, Goridis C. Occurrence of alpha 2-8 linked polysialosyl units in a neural cell adhesion molecule. Biochem Biophys Res Commun 1983; 112:482-7.
9. Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 1983; 2:355-7. (Pubitemid 13028927)
10. Rougon G, Dubois C, Buckley N, Magnani JL, Zollinger W. A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM. J Cell Biol 1986; 103: 2429-37. (Pubitemid 17216667)
11. Nedelec J, Boucraut J, Garnier JM, Bernard D, Rougon G. Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis. J Neuroimmunol 1990; 29:49-56. (Pubitemid 20283781)
12. Stein DM, Robbins J, Miller MA, Lin FY, Schneerson R. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology? Vaccine 2006; 24:221-8. (Pubitemid 41790424)
13. Howitz M, Krause TG, Simonsen JB, et al. Lack of association between group B meningococcal disease and autoimmune disease. Clin Infect Dis 2007; 45:1327-34. (Pubitemid 351411909)
14. Howitz MF, Simonsen J, Krause TG, et al. Risk of adverse birth outcome after group B meningococcal disease: results from a Danish national cohort. Pediatr Infect Dis J 2009; 28:199-203.
15. Statistics Iceland. Population. http://statice.is/Statistics/Population/ Overview. Accessed 10 March 2011.
16. Thomson AP, Sills JA, Hart CA. Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey. Crit Care Med 1991; 19:26-30.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29. (Pubitemid 15250137)
18. Arnarson TO, Olason DT, Smari J, Sigurethsson JF. The Beck Depression Inventory Second Edition (BDI-II): psychometric properties in Icelandic student and patient populations. Nord J Psychiatry 2008; 62:360-5.
19. Ingimarsson B. Pró ffræ+ilegt man á DASS sjálfsmatskvar+anum-3unglyndi, kv́+i, streita (Psychometric properties of the Depression, Anxiety and Stress Scales (DASS)). Reykjavik, Iceland: University of Iceland, 2010.
20. Pálsdó ttir VE. Réttmæti sjá lfsmatskvar+ans Patient Health Questionnaire (PHQ) gagnvart ge+greiningarvi+talinu Mini International Neuropsychiatric Interview (MINI) vi+ a+ greina ge+raskanir hjá heilsugæslusjú klingum. Reykjavik, Iceland: University of Iceland, 2007.
21. Sutton A, Vann WF, Karpas AB, Stein KE, Schneerson R. An avidinbiotin based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods 1985; 82:215-24. (Pubitemid 16247917)
22. Claesson BA, Schneerson R, Trollfors B, Lagerga°rd T, Taranger J, Robbins JB. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18-to 23-month-old children. J Pediatr 1990; 116:929-31. (Pubitemid 20201706)
23. Devi SJ, Robbins JB, Schneerson R. Antibodies to poly[(2-8)-alpha-N- acetylneuraminic acid] and poly[(2-9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Proc Natl Acad Sci USA 1991; 88:7175-9. (Pubitemid 21915112)
24. Einarsson E, Sigurdsson JF, Gudjonsson GH, Newton AK, Bragason OO. Screening for attention-deficit hyperactivity disorder and co-morbid mental disorders among prison inmates. Nord J Psychiatry 2009: 1-7 [Epub ahead of print].
25. Levy C, Taha MK, Weil Olivier C, et al. Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children. Pediatr Infect Dis J 2010; 29:618-23.
26. Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics 2009; 123:e502-9.
27. Erickson L, De Wals P. Complications and sequelae of meningococcal disease inQuebec, Canada, 1990-1994. Clin Infect Dis 1998; 26:1159-64. (Pubitemid 28215481)
28. Goedvolk CA, von Rosenstiel IA, Bos AP. Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review. Arch Dis Child 2003; 88:927-30. (Pubitemid 37194054)
29. Schaad U. Arthritis in disease due to Neisseria meningitidis. Rev Infect Dis 1980; 2:880-8.
30. Weisfelt M, van de Beek D, Spanjaard L, de Gans J. Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect Dis 2006; 6:64.
31. Finkelstein YAY, Adler Y, Nussinovitch M, Varsano I, Amir J. A new classification for pericarditis associated with meningococcal infection. Eur J Pediatr 1997; 156:585-8. (Pubitemid 27351841)
32. Granoff DM, Kelsey SK, Bijlmer HA, et al. Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease. Clin Diagn Lab Immunol 1995; 2: 574-82.
33. Thomaidou D, Coquillat D, Meintanis S, Noda M, Rougon G, Matsas R. Soluble forms of NCAM and F3 neuronal cell adhesion molecules promote Schwann cell migration: identification of protein tyrosine phosphatases zeta/beta as the putative F3 receptors on Schwann cells. J Neurochem 2001; 78:767-78. (Pubitemid 32777978)
34. Schmand B, de Bruin E, de Gans J, van de Beek D. Cognitive functioning and quality of life nine years after bacterial meningitis. J Infect 2010; 61:330-4.